TY - JOUR
T1 - Understanding the role of radiologists in complex treatment decisions for patients with hepatocellular carcinoma
AU - Kamal, Omar
AU - Horvat, Natally
AU - Arora, Sandeep
AU - Chaudhry, Humaira
AU - Elmohr, Mohab
AU - Khanna, Lokesh
AU - Nepal, Pankaj Sharma
AU - Wungjramirun, Manida
AU - Nandwana, Sadhna B.
AU - Shenoy-Bhangle, Anuradha S.
AU - Lee, James
AU - Kielar, Ania
AU - Marks, Robert
AU - Elsayes, Khaled
AU - Fung, Alice
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2023/12
Y1 - 2023/12
N2 - Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver and represents a significant global health burden. Management of HCC can be challenging due to multiple factors, including variable expectations for treatment outcomes. Several treatment options are available, each with specific eligibility and ineligibility criteria, and are provided by a multidisciplinary team of specialists. Radiologists should be aware of the types of treatment options available, as well as the criteria guiding the development of individualized treatment plans. This awareness enables radiologists to contribute effectively to patient-centered multidisciplinary tumor boards for HCC and play a central role in reassessing care plans when the treatment response is deemed inadequate. This comprehensive review aims to equip radiologists with an overview of HCC staging systems, treatment options, and eligibility criteria. The review also discusses the significance of imaging in HCC diagnosis, treatment planning, and monitoring treatment response. Furthermore, we highlight the crucial branch points in the treatment decision-making process that depend on radiological interpretation. Graphical abstract: [Figure not available: see fulltext.]
AB - Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver and represents a significant global health burden. Management of HCC can be challenging due to multiple factors, including variable expectations for treatment outcomes. Several treatment options are available, each with specific eligibility and ineligibility criteria, and are provided by a multidisciplinary team of specialists. Radiologists should be aware of the types of treatment options available, as well as the criteria guiding the development of individualized treatment plans. This awareness enables radiologists to contribute effectively to patient-centered multidisciplinary tumor boards for HCC and play a central role in reassessing care plans when the treatment response is deemed inadequate. This comprehensive review aims to equip radiologists with an overview of HCC staging systems, treatment options, and eligibility criteria. The review also discusses the significance of imaging in HCC diagnosis, treatment planning, and monitoring treatment response. Furthermore, we highlight the crucial branch points in the treatment decision-making process that depend on radiological interpretation. Graphical abstract: [Figure not available: see fulltext.]
KW - Hepatocellular carcinoma
KW - Liver cirrhosis
KW - Liver imaging
UR - http://www.scopus.com/inward/record.url?scp=85171268224&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85171268224&partnerID=8YFLogxK
U2 - 10.1007/s00261-023-04033-6
DO - 10.1007/s00261-023-04033-6
M3 - Review article
C2 - 37715846
AN - SCOPUS:85171268224
SN - 2366-004X
VL - 48
SP - 3677
EP - 3687
JO - Abdominal Radiology
JF - Abdominal Radiology
IS - 12
ER -